Hepatic FXR: key regulator of whole-body energy metabolism.
about
Estrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export PumpBile acids: emerging role in management of liver diseasesEnergy metabolism in the liverChemoproteomic Profiling of Bile Acid Interacting ProteinsMolecular pathways in non-alcoholic fatty liver disease.Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding.Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy.Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.The direction of cross affects [corrected] obesity after puberty in male but not female offspringThe farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin.MicroRNAs in biliary diseases.Modulation of farnesoid X receptor results in post-translational modification of poly (ADP-ribose) polymerase 1 in the liver.Does bariatric surgery improve adipose tissue function?The significance of the nuclear farnesoid X receptor (FXR) in β cell function.Novel diagnostic and prognostic biomarkers in biliary tract cancer.Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility.Blinded evaluation of farnesoid X receptor (FXR) ligands binding using molecular docking and free energy calculations.Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocytes.Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.The bile acid chenodeoxycholic acid directly modulates metabolic pathways in white adipose tissue in vitro: insight into how bile acids decrease obesity.Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell CulturesMicrobial Factors in Inflammatory Diseases and Cancers.Targeting the gut microbiota by dietary nutrients: A new avenue for human health.Supplementation with an insoluble fiber obtained from carob pod (Ceratonia siliqua L.) rich in polyphenols prevents dyslipidemia in rabbits through SIRT1/PGC-1α pathway.Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.Enhancement of brown fat thermogenesis using chenodeoxycholic acid in mice.What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism?Quantitative profiling of bile acids in blood, adipose tissue, intestine, and gall bladder samples using ultra high performance liquid chromatography-tandem mass spectrometryUpdate on FXR Biology: Promising Therapeutic Target?
P2860
Q24318914-29A09D48-08E1-4A2C-ACF5-35B05C43EBC3Q26796318-D2C59519-2CFF-4C82-8561-9B8AAFA95C2DQ26996783-94F7E426-143A-4518-B933-33D4D9D019D6Q33731122-6403CBBA-385E-496B-95AA-541A47A5D1FCQ33890230-86498865-528C-4A9D-BDBA-17E0A2C79ADDQ34249416-24D6298E-1955-4A83-BBEB-E5A1BC6DA108Q34324898-733D1012-42CC-4AA1-BC57-C31A769A589CQ34366918-B1230513-DF21-4FD6-BE17-BA0B04CF0B21Q35834853-80897FC1-DBFF-4D50-8B49-FF4012AD1ADFQ36020304-D76B9864-9BCC-47F9-BE0E-EAF32D80A65AQ36410357-BCB0E93F-2D18-4D6F-906A-4EFD0263124DQ37174451-28C64B20-7F4E-428B-88F3-A62610997BCFQ37669778-1F5593ED-76FD-464A-840F-02F1BB4265C2Q38052748-98CB3FD6-FA10-4424-85F3-BB942D4EB34AQ38131056-5B1A61C5-AC15-40F5-9674-21A82F45B649Q38305576-656B36FB-0438-499D-9FA9-0756EB814B57Q38597033-AEB0FF18-3B26-450C-AF9B-39267823E49AQ38626000-7233B06B-795B-4F31-A207-799885D1ED2AQ38634986-ED5D8AC6-59F9-4884-B47E-CA4FE8D1AB05Q38681686-93037349-7F1B-4420-B5EE-28B68E8C7C9DQ38834821-33969209-AA93-436D-992F-F69993F692D5Q39659058-C57F49ED-5600-42F7-9539-940F5FE24ED8Q41997065-4CDFFA4B-88FD-4B65-83B3-7B231E909E7AQ46315665-2D352589-125D-44C0-905B-2A55666ED7ABQ47259150-6D94574F-CDBE-4571-80D1-FB7F255E47A1Q47958825-3D947CFB-E2BF-40B6-B634-F0D52210CAC9Q54483838-92EEE493-5EA0-4AE3-85A8-1411CFAA69C7Q55555487-DC18F84E-264A-450C-87BE-5E9A92EA8855Q57012093-F53AD5E8-3B32-4D75-9DCC-3EA22E42804AQ57114776-10DCCEDE-F736-4392-81C7-8B32A7E4FDA9
P2860
Hepatic FXR: key regulator of whole-body energy metabolism.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hepatic FXR: key regulator of whole-body energy metabolism.
@en
Hepatic FXR: key regulator of whole-body energy metabolism.
@nl
type
label
Hepatic FXR: key regulator of whole-body energy metabolism.
@en
Hepatic FXR: key regulator of whole-body energy metabolism.
@nl
prefLabel
Hepatic FXR: key regulator of whole-body energy metabolism.
@en
Hepatic FXR: key regulator of whole-body energy metabolism.
@nl
P50
P1476
Hepatic FXR: key regulator of whole-body energy metabolism.
@en
P304
P356
10.1016/J.TEM.2011.07.002
P577
2011-08-19T00:00:00Z